Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Molecular and Cellular Biology|January 21, 2016
A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and SignalingMargarita Arango-Lievano, Ozge Sensoy, Amélie Borie, et al.Glia|April 12, 2002
Immunohistological localization of the myelinating cell-specific receptor LP(A1)Pascale Cervera, Marilyn Tirard, Sonia Barron, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 2004
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeysAlbert Hsu, Daniel M Togasaki, Erwan Bezard, et al.Chembiochem : a European Journal of Chemical Biology|June 9, 2004
Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligandsUlrich R Mach, Anneke E Hackling, Sylvie Perachon, et al.Journal of Neurochemistry|September 3, 2008
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecidDaniel Alvarez-Fischer, Serge Guerreiro, Stéphane Hunot, et al.The Journal of Comparative Neurology|February 27, 2016
Developmental and adult expression patterns of the G-protein-coupled receptor GPR88 in the rat: Establishment of a dual nuclear-cytoplasmic localizationRenaud Massart, Virginie Mignon, Jennifer Stanic, et al.Journal of Medicinal Chemistry|August 22, 2003
N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligandsAnneke Hackling, Robin Ghosh, Sylvie Perachon, et al.Psychopharmacology|September 17, 2009
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studiesOlivier Blin, Christine Audebert, Séverine Pitel, et al.ACS Chemical Biology|March 1, 2022
High-Throughput Screening for Extracellular Inhibitors of the FLT3 Receptor Tyrosine Kinase Reveals Chemically Diverse and Druggable Negative Allosteric ModulatorsRomain Hany, Jean-Philippe Leyris, Guillaume Bret, et al.European Journal of Pharmacology|October 16, 2020
Pharmacology profile of F17464, a dopamine D<sub>3</sub> receptor preferential antagonistCristina Cosi, Jean-Claude Martel, Agnès L Auclair, et al.Pageof 5